N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[6,9-bis(2-aminoethyl)-15-ethylidene-21-(hydroxymethyl)-3-[(4-hydroxyphenyl)methyl]-12,18,25-trimethyl-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-24-yl]amino]-1-oxobut-2-en-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-1-[2-(3-hydroxydodecanoylamino)but-2-enoyl]pyrrolidine-2-carboxamide
| Internal ID | 4244874d-6014-495f-a508-c80b125a9513 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[6,9-bis(2-aminoethyl)-15-ethylidene-21-(hydroxymethyl)-3-[(4-hydroxyphenyl)methyl]-12,18,25-trimethyl-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-24-yl]amino]-1-oxobut-2-en-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-1-[2-(3-hydroxydodecanoylamino)but-2-enoyl]pyrrolidine-2-carboxamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C104H170N24O27/c1-24-28-29-30-31-32-33-35-67(131)49-78(132)115-70(27-4)103(153)128-45-34-36-77(128)98(148)126-81(55(13)14)101(151)121-73(46-51(5)6)95(145)111-56(15)83(133)108-60(19)89(139)120-74(47-52(7)8)96(146)125-80(54(11)12)100(150)114-58(17)85(135)109-63(22)90(140)124-79(53(9)10)99(149)113-57(16)84(134)107-59(18)86(136)117-69(26-3)92(142)127-82-64(23)155-104(154)75(48-65-37-39-66(130)40-38-65)122-94(144)72(42-44-106)119-93(143)71(41-43-105)118-88(138)62(21)110-91(141)68(25-2)116-87(137)61(20)112-97(147)76(50-129)123-102(82)152/h25-27,37-40,51-64,67,71-77,79-82,129-131H,24,28-36,41-50,105-106H2,1-23H3,(H,107,134)(H,108,133)(H,109,135)(H,110,141)(H,111,145)(H,112,147)(H,113,149)(H,114,150)(H,115,132)(H,116,137)(H,117,136)(H,118,138)(H,119,143)(H,120,139)(H,121,151)(H,122,144)(H,123,152)(H,124,140)(H,125,146)(H,126,148)(H,127,142) |
| InChI Key | HHDQRNAQGXUIRL-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C104H170N24O27 |
| Molecular Weight | 2188.60 g/mol |
| Exact Mass | 2188.2700811 g/mol |
| Topological Polar Surface Area (TPSA) | 770.00 Ų |
| XlogP | 4.30 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| No predicted properties yet! | |||
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.93% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.89% | 96.61% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.78% | 89.63% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 99.68% | 93.10% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.98% | 91.11% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 98.47% | 97.09% |
| CHEMBL4072 | P07858 | Cathepsin B | 98.46% | 93.67% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.21% | 100.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.15% | 96.09% |
| CHEMBL236 | P41143 | Delta opioid receptor | 98.14% | 99.35% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.00% | 97.25% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.70% | 93.56% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 97.56% | 97.64% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 97.51% | 94.66% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 97.19% | 90.08% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 97.16% | 99.17% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.93% | 94.45% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.41% | 98.33% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 96.28% | 90.93% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 96.15% | 92.88% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 95.34% | 97.14% |
| CHEMBL3468 | P55210 | Caspase-7 | 95.13% | 95.68% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 95.13% | 82.38% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.99% | 90.71% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 94.98% | 100.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 94.73% | 96.47% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 94.30% | 95.20% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 94.16% | 92.86% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.82% | 95.56% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 93.72% | 92.12% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 93.30% | 91.19% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 93.01% | 91.38% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 92.70% | 96.90% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.67% | 100.00% |
| CHEMBL301 | P24941 | Cyclin-dependent kinase 2 | 92.37% | 91.23% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 92.05% | 98.10% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 91.54% | 97.29% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 90.55% | 94.80% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 90.03% | 95.50% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 89.67% | 100.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 89.02% | 98.05% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 89.01% | 97.23% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 88.56% | 92.32% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 88.27% | 85.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 88.00% | 95.00% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 87.96% | 88.10% |
| CHEMBL268 | P43235 | Cathepsin K | 87.73% | 96.85% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.31% | 95.89% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 87.22% | 91.81% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 87.05% | 95.89% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 86.79% | 95.38% |
| CHEMBL4801 | P29466 | Caspase-1 | 85.65% | 96.85% |
| CHEMBL242 | Q92731 | Estrogen receptor beta | 85.42% | 98.35% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 85.23% | 88.56% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 84.73% | 92.08% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 84.64% | 93.03% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 84.33% | 96.33% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 83.94% | 96.11% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 83.84% | 94.33% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 83.72% | 92.38% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 83.54% | 98.03% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 83.16% | 88.42% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 83.14% | 98.89% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 82.69% | 93.18% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 82.63% | 93.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 81.22% | 96.67% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 81.12% | 89.00% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 80.98% | 95.83% |
| CHEMBL227 | P30556 | Type-1 angiotensin II receptor | 80.29% | 99.53% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 162971358 |
| LOTUS | LTS0202192 |
| wikiData | Q104167852 |